BusinessPetLife Pharmaceuticals Announces the Addition of a Seasoned Marketing Specialist and Investor, Mrs. Vyvyan Campbell, to the Board of DirectorsBy Nasdaq OMXOct 24, 2016, 4:00 PM UTC
BusinessPetLife Pharmaceuticals Expands Cell Line Study with InnoVision in Preparation for FDA/CVM Registration SubmissionBy Nasdaq OMXOct 13, 2016, 12:02 PM UTC
BusinessVCA Inc. to Present at 25th Annual Credit Suisse Healthcare ConferenceBy Nasdaq OMXOct 10, 2016, 10:10 PM UTC
BusinessPetLife Pharmaceuticals is Pleased to Showcase its New “Vitalzul™ Information Video” along with a Corporate UpdateBy Nasdaq OMXOct 10, 2016, 12:00 PM UTC
BusinessPetLife Pharmaceuticals Explores Product Expansion with Strategic Partner(s); Successfully Presents at Two Financial Conferences in SeptemberBy Nasdaq OMXSep 28, 2016, 2:30 PM UTC
BusinessVCA Inc. to Report Third Quarter 2016 Financial ResultsBy Nasdaq OMXSep 16, 2016, 12:00 AM UTC
BusinessPetLife Pharmaceuticals Hires InnoVision Therapeutics in Preparation of Vitalzul™ FDA SubmissionBy Nasdaq OMXAug 25, 2016, 12:43 PM UTC
